Rafferty Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Buy |
80,846
+5,524
| +7% | +$96.4K | ﹤0.01% | 692 |
|
|
2025
Q1 | $948K | Sell |
75,322
-65,050
| -46% | -$818K | ﹤0.01% | 753 |
|
|
2024
Q4 | $1.48M | Buy |
140,372
+59,097
| +73% | +$623K | 0.01% | 716 |
|
|
2024
Q3 | $1.18M | Sell |
81,275
-4,042
| -5% | -$58.6K | ﹤0.01% | 769 |
|
|
2024
Q2 | $726K | Sell |
85,317
-26,242
| -24% | -$223K | ﹤0.01% | 873 |
|
|
2024
Q1 | $1.14M | Buy |
+111,559
| New | +$1.14M | ﹤0.01% | 810 |
|